CompletedPhase 2NCT01360658
Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
Studying Solar urticaria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Principal Investigator
- François Aubin, PrUniversity Hospital of Besançon
- Intervention
- Intravenous immunoglobulins(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2011 – 2013
Study locations (12)
- Regional University Hospital, Besançon, France
- University Hospital, Caen, France
- University Hospital, Grenoble, France
- Regional University Hospital, Lille, France
- University hospital, Limoges, France
- Regional University Hospital, Montpellier, France
- University Hospital, Nancy, France
- University Hospital, Nîmes, France
- Saint louis Hospital, Paris, France
- University Hospital, Reims, France
- University Hospital, Rennes, France
- University Hospital, Toulouse, France
Collaborators
Ministry of Health, France · Saint-Louis Hospital, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01360658 on ClinicalTrials.gov